Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Hertlein

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Oncotarget|January 18, 2015
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemiaKati Kämpjärvi, Tiina M Järvinen, Tuomas Heikkinen, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Cancers|February 10, 2024
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid LeukemiaSydney Fobare, Ola A Elgamal, Mark Wunderlich, et al.
Journal of Hematology & Oncology|January 30, 2020
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemiaOla A Elgamal, Abeera Mehmood, Jae Yoon Jeon, et al.
Blood|January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphomaLapo Alinari, Bo Yu, Beth A Christian, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionJennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Blood|October 9, 2014
OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cellsTa-Ming Liu, Yonghua Ling, Jennifer A Woyach, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Oncotarget|January 18, 2015
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemiaKati Kämpjärvi, Tiina M Järvinen, Tuomas Heikkinen, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Cancers|February 10, 2024
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid LeukemiaSydney Fobare, Ola A Elgamal, Mark Wunderlich, et al.
Journal of Hematology & Oncology|January 30, 2020
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemiaOla A Elgamal, Abeera Mehmood, Jae Yoon Jeon, et al.
Blood|January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphomaLapo Alinari, Bo Yu, Beth A Christian, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionJennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Blood|October 9, 2014
OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cellsTa-Ming Liu, Yonghua Ling, Jennifer A Woyach, et al.
Pageof 5